13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001937964-24-000004
Total Value
$497.5M
Positions
49
Other Managers
0
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 115,000 | $89.5M | 17.98% |
| 2 | NOVO-NORDISK A S | NONOF | 691,743 | $88.8M | 17.85% |
| 3 | ELI LILLY & CO | LLY | 92,593 | $72.0M | 14.48% |
| 4 | MERCK & CO INC | MRK | 379,200 | $50.0M | 10.06% |
| 5 | VIKING THERAPEUTICS INC | VKTX | 433,580 | $35.6M | 7.15% |
| 6 | ABBVIE INC | ABBV | 90,821 | $16.5M | 3.32% |
| 7 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 210,096 | $14.5M | 2.92% |
| 8 | ARGENX SE | ARGX | 34,238 | $13.5M | 2.71% |
| 9 | ASTRAZENECA PLC | AZN | 190,752 | $12.9M | 2.60% |
| 10 | VERTEX PHARMACEUTICALS INC | VRTX | 28,900 | $12.1M | 2.43% |
| 11 | AXSOME THERAPEUTICS INC | AXSM | 87,848 | $7.0M | 1.41% |
| 12 | OCULAR THERAPEUTIX INC | OCUL | 724,685 | $6.6M | 1.33% |
| 13 | CYTOKINETICS INC | CYTK | 89,525 | $6.3M | 1.26% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 45,000 | $6.2M | 1.25% |
| 15 | DISC MEDICINE INC | IRON | 87,040 | $5.4M | 1.09% |
| 16 | VAXCYTE INC | PCVX | 76,255 | $5.2M | 1.05% |
| 17 | APOGEE THERAPEUTICS INC | APGE | 61,590 | $4.1M | 0.82% |
| 18 | CRINETICS PHARMACEUTICALS IN | CRNX | 85,765 | $4.0M | 0.81% |
| 19 | PROTAGONIST THERAPEUTICS INC | PTGX | 124,440 | $3.6M | 0.72% |
| 20 | DYNE THERAPEUTICS INC | DYN | 119,488 | $3.4M | 0.68% |
| 21 | INSMED INC | INSM | 118,236 | $3.2M | 0.64% |
| 22 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 53,930 | $2.7M | 0.53% |
| 23 | ASCENDIS PHARMA A/S | ASND | 15,894 | $2.4M | 0.48% |
| 24 | IDEAYA BIOSCIENCES INC | IDYA | 52,492 | $2.3M | 0.46% |
| 25 | MERUS N V | N5749R100 | 50,171 | $2.3M | 0.45% |
| 26 | VERONA PHARMA PLC | 925050106 | 130,790 | $2.1M | 0.42% |
| 27 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 51,714 | $2.0M | 0.41% |
| 28 | CHARLES RIV LABS INTL INC | 159864107 | 6,905 | $1.9M | 0.38% |
| 29 | JANUX THERAPEUTICS INC | JANX | 47,949 | $1.8M | 0.36% |
| 30 | SOLENO THERAPEUTICS INC | SLNO | 40,924 | $1.8M | 0.35% |
| 31 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.7M | 0.35% |
| 32 | ARVINAS INC | ARVN | 40,000 | $1.7M | 0.33% |
| 33 | PLIANT THERAPEUTICS INC | PLRX | 100,000 | $1.5M | 0.30% |
| 34 | MEREO BIOPHARMA GROUP PLC | MREO | 421,359 | $1.4M | 0.28% |
| 35 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 54,285 | $1.3M | 0.26% |
| 36 | RAPT THERAPEUTICS INC | 75382E109 | 137,308 | $1.2M | 0.25% |
| 37 | SILENCE THERAPEUTICS PLC | SLNCF | 52,476 | $1.1M | 0.23% |
| 38 | EYEPOINT PHARMACEUTICALS INC | EYPT | 51,500 | $1.1M | 0.21% |
| 39 | ANNEXON INC | ANNX | 147,485 | $1.1M | 0.21% |
| 40 | VERA THERAPEUTICS INC | VERA | 24,298 | $1.0M | 0.21% |
| 41 | MACROGENICS INC | MGNX | 64,007 | $942,183 | 0.19% |
| 42 | KURA ONCOLOGY INC | KURA | 39,478 | $842,066 | 0.17% |
| 43 | IMMUNOVANT INC | IMVT | 21,397 | $691,337 | 0.14% |
| 44 | BIOMEA FUSION INC | BMEA | 35,452 | $530,007 | 0.11% |
| 45 | LARIMAR THERAPEUTICS INC | LRMR | 58,190 | $441,662 | 0.09% |
| 46 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,557 | $415,781 | 0.08% |
| 47 | EFFECTOR THERAPEUTICS INC | 28202V907 | 25,000 | $359,750 | 0.07% |
| 48 | POSEIDA THERAPEUTICS INC | 73730P108 | 86,002 | $274,346 | 0.06% |
| 49 | GRITSTONE BIO INC | 39868T105 | 95,170 | $244,587 | 0.05% |